APA (7th ed.) Citation

Tian, L., Wang, M., Liu, M., Pang, Y., Zhao, J., Zheng, B., . . . Zhao, W. Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: A systematic review and meta-analysis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Tian, Lei, Mengdi Wang, Mengchao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, and Wenjing Zhao. Cardiovascular and Renal Safety Outcomes of Hypoxia-inducible Factor Prolyl-hydroxylase Inhibitor Roxadustat for Anemia Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis. Taylor & Francis Group.

MLA (9th ed.) Citation

Tian, Lei, et al. Cardiovascular and Renal Safety Outcomes of Hypoxia-inducible Factor Prolyl-hydroxylase Inhibitor Roxadustat for Anemia Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis. Taylor & Francis Group.